TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Chabner Says John Antoine Of New Mexico May Head radiation Program; GM Winners Announced June 14, 1985
TCL Archive House Committee Expands Rauscher Pay Bill, Includes All NIH Directors, Asst. Secretary July 30, 1976
TCL Archive Senate Bill Would Require Clinical Trials To Test Gender, Racial Differences In Therapies August 10, 1990
